FDA warns Amgen over misleading Vectibix cancer drug promotional video
The US FDA warned Amgen that a promotional video for its colorectal cancer drug Vectibix was misleading because it highlighted benefits while failing to adequately disclose serious safety risks and patient limitations. The warning letter was issued on Tuesday.
